Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kojima

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Biochimica Et Biophysica Acta|November 25, 1997
Lack of effect of transmembrane gradient of magnesium and sodium on regulation of cytosolic free magnesium concentration in rat lymphocytesN Sasaki, T Oshima, H Matsuura, et al.
Bone Marrow Transplantation|December 17, 2003
Urgent need for a validated tumor response evaluation system for use in immunotherapyA Hori, M Kami, S-W Kim, et al.
Bone Marrow Transplantation|January 25, 2005
Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic stem cell transplantationA Chizuka, M Kami, Y Kanda, et al.
Bone Marrow Transplantation|March 15, 2005
Graft-versus-host disease of the kidney after rapid tapering of cyclosporin following reduced intensity hematopoietic stem cell transplantationC I Homma, M Kami, S Masuo, et al.
Bone Marrow Transplantation|August 6, 2003
Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantationR Kojima, M Kami, S-W Kim, et al.
Bone Marrow Transplantation|March 30, 2004
Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignanciesT Hamaki, M Kami, S-W Kim, et al.
Bone Marrow Transplantation|September 14, 2004
Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST): comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0M Sakiyama, M Kami, A Hori, et al.
Immunity|November 7, 1998
Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane proteinN Utku, T Heinemann, S G Tullius, et al.
Bone Marrow Transplantation|February 3, 2004
Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donorE Kusumi, M Kami, K Yuji, et al.
Bone Marrow Transplantation|August 23, 2005
Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 yearsR Kojima, M Kami, Y Kanda, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Biochimica Et Biophysica Acta|November 25, 1997
Lack of effect of transmembrane gradient of magnesium and sodium on regulation of cytosolic free magnesium concentration in rat lymphocytesN Sasaki, T Oshima, H Matsuura, et al.
Bone Marrow Transplantation|December 17, 2003
Urgent need for a validated tumor response evaluation system for use in immunotherapyA Hori, M Kami, S-W Kim, et al.
Bone Marrow Transplantation|January 25, 2005
Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic stem cell transplantationA Chizuka, M Kami, Y Kanda, et al.
Bone Marrow Transplantation|March 15, 2005
Graft-versus-host disease of the kidney after rapid tapering of cyclosporin following reduced intensity hematopoietic stem cell transplantationC I Homma, M Kami, S Masuo, et al.
Bone Marrow Transplantation|August 6, 2003
Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantationR Kojima, M Kami, S-W Kim, et al.
Bone Marrow Transplantation|March 30, 2004
Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignanciesT Hamaki, M Kami, S-W Kim, et al.
Bone Marrow Transplantation|September 14, 2004
Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST): comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0M Sakiyama, M Kami, A Hori, et al.
Immunity|November 7, 1998
Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane proteinN Utku, T Heinemann, S G Tullius, et al.
Bone Marrow Transplantation|February 3, 2004
Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donorE Kusumi, M Kami, K Yuji, et al.
Bone Marrow Transplantation|August 23, 2005
Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 yearsR Kojima, M Kami, Y Kanda, et al.
Pageof 11